Biocon Ltd, an indian biotech company are developing an oral insulin.1N-105 is a novel analog of insulin. Phase 1 studies show promising results. A potential competitor for aop.
AOP Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
